We are live on ! Find out more
HHMI

Howard Hughes Medical Institute Portfolio holdings

AUM $416M
1-Year Est. Return 13.82%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+13.82%
3 Year Est. Return
+59.34%
5 Year Est. Return
+48.21%
10 Year Est. Return
+227.75%
AUM
$342M
AUM Growth
-$53.4M
Cap. Flow
-$66.3M
Cap. Flow %
-19.36%
Top 10 Hldgs %
77.38%
Holding
27
New
Increased
Reduced
6
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$49M
2
TM icon
Toyota
TM
+$6.95M
3
MA icon
Mastercard
MA
+$4.17M
4
SONY icon
Sony
SONY
+$3.3M
5
KBE icon
State Street SPDR S&P Bank ETF
KBE
+$1.46M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 9.27%
2 Financials 7.51%
3 Technology 4.68%
4 Healthcare 3.34%
5 Communication Services 3.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMYT icon
26
MakeMyTrip
MMYT
$5.64B
$1.91M 0.56%
69,680
DVAX
27
DELISTED
Dynavax Technologies
DVAX
$265K 0.08%
21,355

Similar funds

Howard Hughes Medical Institute's Q3 2018 Portfolio in Review

As of Q3 2018, Howard Hughes Medical Institute held 27 positions worth $342M, down 13% from $396M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Howard Hughes Medical Institute withdrew a net $66.3M in Q3 2018, reducing 6 holdings. Its largest reduction was iShares MSCI EAFE ETF, cutting an estimated $49M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 9.3% of assets, down from 9.6% a quarter earlier, followed by Financials and Technology.

  • Howard Hughes Medical Institute's biggest Q3 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $49M.
  • Howard Hughes Medical Institute's ten largest holdings make up 77% of its $342M portfolio in Q3 2018.
  • Howard Hughes Medical Institute opened 0 new positions and closed 0 in Q3 2018.
  • Howard Hughes Medical Institute's portfolio value fell 13% quarter-over-quarter to $342M.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2018, filed 9 Nov 2018.